Low-Dose Aspirin as Primary Prophylaxis for Cardiovascular Events in Rheumatoid Arthritis: An Italian Multicentre Retrospective Study.
Daniela IaconoSerena FasanoIlenia PantanoVirginia D'AbroscaRoberto CaporaliDomenico Paolo Emanuele MargiottaLuca NavariniNicola MaruottiRosa Daniela GrembialeFrancesco Paolo CantatoreAntonella AfeltraRoberto GiacomelliGabriele ValentiniPublished in: Cardiology research and practice (2019)
The IR of CV events in our Italian multicentre cohort was lower than that reported in other European and non-European cohorts. Low-dose ASA may have a role in the primary prophylaxis of CV events in RA patients.
Keyphrases
- low dose
- cardiovascular events
- rheumatoid arthritis
- end stage renal disease
- coronary artery disease
- high dose
- cardiovascular disease
- clinical trial
- ejection fraction
- newly diagnosed
- disease activity
- chronic kidney disease
- study protocol
- peritoneal dialysis
- prognostic factors
- cross sectional
- double blind
- ankylosing spondylitis
- randomized controlled trial
- systemic sclerosis
- systemic lupus erythematosus
- percutaneous coronary intervention
- atrial fibrillation